Today's Change
+0.85%
AI Sentiment
59%
Sector AnalysisLive data
Materials Sector Outlook
The Materials sector is up 0.85% today with neutral sentiment across 15 recent news articles. Top movers include $CDTTW (+65.33%), $ERNAW (+63.87%), $TMCWW (+60.68%).
Bullish Factors
- No strong bullish signals detected
Risk Factors
- No strong bearish signals detected
Stocks in Materials
198 stocks| Symbol | Company | Change |
|---|---|---|
| $SRZNW | Surrozen Inc - Warrants (01/08/2026) | +5.00% |
| $DRMAW | Dermata Therapeutics Inc - Warrants (13/08/2026) | -8.87% |
| $ERNAW | Ernexa Therapeutics Inc. Warrants | +63.87% |
| $SEE | Sealed Air Corp. | +0.00% |
| $AIMDW | Ainos Inc - Warrants (29/07/2027) | -24.11% |
| $CDIOW | Cardio Diagnostics Holdings Inc | -11.72% |
| $JSPRW | Jasper Therapeutics Inc - Warrants (24/09/2026) | -15.64% |
| $BIVIW | BioVie Inc Warrant | +9.38% |
| $ANABV | AnaptysBio, Inc. Common Stock When Issued | +0.00% |
| $BCTXL | BriaCell Therapeutics Corp Warrants | +7.53% |
| $VACHW | Voyager Acquisition Corp. | -1.91% |
| $ASBPW | Aspire Biopharma Holdings Inc - Warrants (18/02/2030) | +7.88% |
| $HUMAW | Humacyte Inc | +5.13% |
| $TMCWW | TMC the metals company Inc - Warrants (09/09/2026) | +60.68% |
| $NBY | NovaBay Pharmaceuticals, Inc. | +0.00% |
Materials News
806 articlesGlobeNewswire Inc.38d ago
RenovoRx Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026

Benzinga38d ago
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--VYNE, MASI, IBCP, and HCBN
GlobeNewswire Inc.38d ago
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Gossamer Bio, Inc. (GOSS)
GlobeNewswire Inc.38d ago
Bronstein, Gewirtz & Grossman LLC Urges Coty Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire Inc.38d ago
Bronstein, Gewirtz & Grossman LLC Urges Aldeyra Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire Inc.38d ago
Bronstein, Gewirtz & Grossman LLC Urges Ultragenyx Pharmaceutical Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire Inc.38d ago
Rapport Therapeutics to Present New Phase 2 Treatment Follow-Up Data for RAP-219 in Focal Onset Seizures at the 2026 American Academy of Neurology Annual Meeting

Benzinga38d ago
U.S. Gold Corp. Highlights Additional Value Opportunities Beyond CK Gold Project Feasibility Study
GlobeNewswire Inc.38d ago
Proleukin Market Research Report 2026-2035: Epidemiology, Pipeline Analysis, Industry Insights and More

Market Sentiment
Neutral
59% Sentiment Score
Sector Stats
Total Stocks198
News Today15
Avg Volume1.3M
AI SentimentNeutral